Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolic Syndrome | 3 | 2013 | 77 | 0.840 |
Why?
|
| Obesity | 3 | 2011 | 654 | 0.460 |
Why?
|
| Epidermis | 1 | 2013 | 11 | 0.420 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 17 | 0.420 |
Why?
|
| Adult Stem Cells | 1 | 2013 | 10 | 0.420 |
Why?
|
| Regenerative Medicine | 1 | 2013 | 17 | 0.420 |
Why?
|
| Elasticity | 1 | 2012 | 49 | 0.410 |
Why?
|
| Regeneration | 1 | 2013 | 76 | 0.400 |
Why?
|
| Arteries | 1 | 2012 | 65 | 0.390 |
Why?
|
| Edema | 1 | 2012 | 18 | 0.390 |
Why?
|
| Cystic Fibrosis | 1 | 2012 | 32 | 0.380 |
Why?
|
| Walking | 1 | 2013 | 130 | 0.370 |
Why?
|
| Adipose Tissue | 1 | 2012 | 180 | 0.370 |
Why?
|
| Radial Artery | 1 | 2011 | 21 | 0.370 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 106 | 0.360 |
Why?
|
| Insulin | 1 | 2012 | 315 | 0.340 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 213 | 0.320 |
Why?
|
| Child | 7 | 2024 | 2160 | 0.310 |
Why?
|
| Leuprolide | 1 | 2006 | 5 | 0.270 |
Why?
|
| Human Growth Hormone | 1 | 2006 | 14 | 0.270 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 2006 | 11 | 0.270 |
Why?
|
| Adolescent | 7 | 2024 | 2988 | 0.260 |
Why?
|
| Hydrocortisone | 1 | 2006 | 88 | 0.260 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2006 | 45 | 0.250 |
Why?
|
| Alaska Natives | 1 | 2024 | 5 | 0.230 |
Why?
|
| Diabetes, Gestational | 1 | 2024 | 63 | 0.210 |
Why?
|
| Caregivers | 1 | 2024 | 112 | 0.200 |
Why?
|
| Humans | 15 | 2024 | 27121 | 0.200 |
Why?
|
| Young Adult | 5 | 2024 | 2626 | 0.200 |
Why?
|
| Cell Movement | 3 | 2012 | 353 | 0.200 |
Why?
|
| Case-Control Studies | 3 | 2013 | 705 | 0.190 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2024 | 282 | 0.190 |
Why?
|
| Olfaction Disorders | 1 | 2020 | 4 | 0.170 |
Why?
|
| Practice Guidelines as Topic | 2 | 2012 | 234 | 0.170 |
Why?
|
| Nose | 1 | 2020 | 22 | 0.170 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2020 | 37 | 0.170 |
Why?
|
| Medical Overuse | 1 | 2020 | 3 | 0.170 |
Why?
|
| Female | 8 | 2024 | 14636 | 0.170 |
Why?
|
| Age Factors | 2 | 2013 | 721 | 0.170 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 112 | 0.160 |
Why?
|
| Male | 7 | 2020 | 13022 | 0.150 |
Why?
|
| Neurons | 1 | 2020 | 276 | 0.150 |
Why?
|
| Body Mass Index | 2 | 2011 | 389 | 0.140 |
Why?
|
| Patient Care Team | 2 | 2020 | 63 | 0.130 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 928 | 0.130 |
Why?
|
| Disorders of Sex Development | 2 | 2012 | 13 | 0.120 |
Why?
|
| Electrophysiological Phenomena | 2 | 2012 | 16 | 0.120 |
Why?
|
| Electric Stimulation | 2 | 2012 | 253 | 0.120 |
Why?
|
| Wound Healing | 2 | 2012 | 113 | 0.120 |
Why?
|
| Hypertension | 2 | 2006 | 305 | 0.110 |
Why?
|
| Cell Transdifferentiation | 1 | 2013 | 2 | 0.110 |
Why?
|
| Accelerometry | 1 | 2013 | 11 | 0.100 |
Why?
|
| Cell Lineage | 1 | 2013 | 45 | 0.100 |
Why?
|
| Manometry | 1 | 2012 | 36 | 0.100 |
Why?
|
| Electromagnetic Fields | 1 | 2012 | 14 | 0.100 |
Why?
|
| Cell Proliferation | 2 | 2013 | 774 | 0.100 |
Why?
|
| Animals | 6 | 2013 | 10085 | 0.100 |
Why?
|
| Transition to Adult Care | 1 | 2012 | 8 | 0.100 |
Why?
|
| Neural Stem Cells | 1 | 2012 | 13 | 0.100 |
Why?
|
| Linear Models | 1 | 2012 | 201 | 0.100 |
Why?
|
| Adiposity | 1 | 2013 | 88 | 0.100 |
Why?
|
| Adult | 4 | 2024 | 7492 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 299 | 0.100 |
Why?
|
| Lens, Crystalline | 1 | 2011 | 6 | 0.100 |
Why?
|
| Glycated Hemoglobin A | 1 | 2012 | 64 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 1 | 2013 | 138 | 0.100 |
Why?
|
| Skin Neoplasms | 1 | 2013 | 118 | 0.100 |
Why?
|
| Risk Factors | 3 | 2024 | 2030 | 0.090 |
Why?
|
| Cornea | 1 | 2011 | 65 | 0.090 |
Why?
|
| Body Fat Distribution | 1 | 2011 | 15 | 0.090 |
Why?
|
| Compliance | 1 | 2011 | 21 | 0.090 |
Why?
|
| Puberty | 1 | 2011 | 13 | 0.090 |
Why?
|
| Sex Factors | 1 | 2013 | 452 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2012 | 241 | 0.090 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2011 | 91 | 0.090 |
Why?
|
| Body Composition | 1 | 2012 | 262 | 0.090 |
Why?
|
| Cell Differentiation | 1 | 2013 | 398 | 0.090 |
Why?
|
| Wounds and Injuries | 1 | 2012 | 166 | 0.090 |
Why?
|
| Graves Disease | 1 | 2009 | 8 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2011 | 351 | 0.080 |
Why?
|
| Receptor, Muscarinic M2 | 1 | 2009 | 15 | 0.080 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2009 | 22 | 0.080 |
Why?
|
| Time Factors | 1 | 2013 | 1570 | 0.080 |
Why?
|
| Quality of Life | 1 | 2011 | 465 | 0.070 |
Why?
|
| Steroid 11-beta-Hydroxylase | 1 | 2006 | 1 | 0.070 |
Why?
|
| Puberty, Precocious | 1 | 2006 | 6 | 0.070 |
Why?
|
| Delayed-Action Preparations | 1 | 2006 | 39 | 0.070 |
Why?
|
| Exercise | 1 | 2011 | 469 | 0.070 |
Why?
|
| Body Height | 1 | 2006 | 58 | 0.070 |
Why?
|
| Autoantibodies | 1 | 2009 | 472 | 0.070 |
Why?
|
| Kidney Transplantation | 1 | 2006 | 44 | 0.060 |
Why?
|
| Sleep Wake Disorders | 1 | 2006 | 65 | 0.060 |
Why?
|
| Bone Density | 1 | 2006 | 99 | 0.060 |
Why?
|
| Genotype | 1 | 2006 | 443 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2009 | 398 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2006 | 186 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2006 | 404 | 0.060 |
Why?
|
| Insulin Resistance | 1 | 2006 | 172 | 0.060 |
Why?
|
| Disease Progression | 1 | 2006 | 458 | 0.060 |
Why?
|
| Mothers | 1 | 2024 | 112 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2006 | 635 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2005 | 324 | 0.050 |
Why?
|
| Gonads | 1 | 2020 | 7 | 0.040 |
Why?
|
| Olfactory Pathways | 1 | 2020 | 9 | 0.040 |
Why?
|
| Hypogonadism | 1 | 2020 | 5 | 0.040 |
Why?
|
| Organ Size | 1 | 2020 | 85 | 0.040 |
Why?
|
| Luteinizing Hormone | 1 | 2020 | 57 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2020 | 22 | 0.040 |
Why?
|
| Abnormalities, Multiple | 1 | 2020 | 34 | 0.040 |
Why?
|
| Social Work | 1 | 2020 | 15 | 0.040 |
Why?
|
| Pregnancy | 1 | 2024 | 1149 | 0.040 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2020 | 71 | 0.040 |
Why?
|
| Indians, North American | 1 | 2024 | 514 | 0.040 |
Why?
|
| Cooperative Behavior | 1 | 2020 | 74 | 0.040 |
Why?
|
| Interprofessional Relations | 1 | 2020 | 63 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2020 | 863 | 0.040 |
Why?
|
| Infant | 1 | 2020 | 966 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 1100 | 0.030 |
Why?
|
| Middle Aged | 2 | 2020 | 6900 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 23 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 86 | 0.030 |
Why?
|
| Mice | 2 | 2012 | 4474 | 0.020 |
Why?
|
| Vibration | 1 | 2012 | 78 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2012 | 55 | 0.020 |
Why?
|
| Static Electricity | 1 | 2012 | 34 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 133 | 0.020 |
Why?
|
| Child Health Services | 1 | 2011 | 7 | 0.020 |
Why?
|
| Ion Transport | 1 | 2011 | 11 | 0.020 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2011 | 13 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 19 | 0.020 |
Why?
|
| Long-Term Care | 1 | 2011 | 30 | 0.020 |
Why?
|
| Microscopy | 1 | 2012 | 38 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 285 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 153 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 2011 | 34 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 546 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 506 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2011 | 130 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 5222 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 247 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 977 | 0.020 |
Why?
|
| Purkinje Fibers | 1 | 2009 | 37 | 0.020 |
Why?
|
| Atropine | 1 | 2009 | 47 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2009 | 61 | 0.020 |
Why?
|
| Cricetinae | 1 | 2009 | 129 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 1554 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2009 | 117 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 988 | 0.020 |
Why?
|
| Dogs | 1 | 2009 | 505 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2011 | 846 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 267 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 1496 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2012 | 1379 | 0.020 |
Why?
|
| Drinking Behavior | 1 | 2005 | 6 | 0.020 |
Why?
|
| Health Behavior | 1 | 2005 | 154 | 0.010 |
Why?
|
| Diet | 1 | 2005 | 226 | 0.010 |
Why?
|